Jonathan Gill
Overview
Explore the profile of Jonathan Gill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fritz C, Basta A, Gill J, Lewis V, Bird J, Austin M
J Pediatr Surg
. 2025 Feb;
60(4):162202.
PMID: 39908921
Background: In our population-based study, we examine the impact of patient demographics on disease presentation, treatment and survival for children, adolescents, and young adults with osteosarcoma. Methods: Patient data was...
2.
Fritz C, Basta A, Gill J, Lewis V, Bird J, Austin M
J Surg Res
. 2024 Oct;
303:322-331.
PMID: 39396459
Introduction: In this study, we evaluate the association between sociodemographics and disease presentation, treatment, and survival for children, adolescents, and young adults with Ewing sarcoma. Methods: Case-level data were downloaded...
3.
Desrosiers-Battu L, Wang T, Reuther J, Miles G, Dai H, Jo E, et al.
JCO Precis Oncol
. 2024 Sep;
8():e2400187.
PMID: 39259914
Purpose: To evaluate the relative diagnostic yield of clinical germline genomic tests in a diverse pediatric cancer population. Patients And Methods: The KidsCanSeq study enrolled pediatric cancer patients across six...
4.
Wu C, Huang L, Zhang Z, Ju Z, Song X, Kolb E, et al.
Sci Rep
. 2024 Aug;
14(1):19891.
PMID: 39191826
Osteosarcoma is the most common primary bone malignancy in children and young adults, and it has few treatment options. As a result, there has been little improvement in survival outcomes...
5.
Vuocolo B, Gutierrez A, Robinson J, Recinos A, Desrosiers L, Majumder M, et al.
J Genet Couns
. 2024 Jan;
33(6):1337-1350.
PMID: 38225886
Access to genomic sequencing (GS) and resulting recommendations have not been well described in pediatric oncology. GS results may provide a cancer predisposition syndrome (CPS) diagnosis that warrants screening and...
6.
Rogers Z, Glaser A, Catto J, Bottomley S, Jubber I, Kotwal S, et al.
BJU Int
. 2023 Nov;
133(4):460-473.
PMID: 38031657
Objectives: To describe the health-related quality of life (HRQoL) of patients in a prospective 12-month observational cohort study of new bladder cancer diagnoses and compare with national cancer and general...
7.
Moody K, Andersen C, Bradley J, Draper L, Garrington T, Gill J, et al.
Res Sq
. 2023 Aug;
PMID: 37609163
Purpose: Effective, empathic communication is crucial for pediatric oncology clinicians when discussing palliative and end-of-life (PC/EOL) care with parents of children with cancer. Unfortunately, many parents report inadequate communication at...
8.
Mangum R, Reuther J, Sen Baksi K, Gandhi I, Zabriskie R, Recinos A, et al.
Pediatr Hematol Oncol
. 2023 Jun;
40(8):719-738.
PMID: 37366551
The potential of circulating tumor DNA (ctDNA) analysis to serve as a real-time "liquid biopsy" for children with central nervous system (CNS) and non-CNS solid tumors remains to be fully...
9.
Beird H, Bielack S, Flanagan A, Gill J, Heymann D, Janeway K, et al.
Nat Rev Dis Primers
. 2022 Dec;
8(1):82.
PMID: 36585406
No abstract available.
10.
Beird H, Bielack S, Flanagan A, Gill J, Heymann D, Janeway K, et al.
Nat Rev Dis Primers
. 2022 Dec;
8(1):77.
PMID: 36481668
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in males....